JP2014516407A5 - - Google Patents

Download PDF

Info

Publication number
JP2014516407A5
JP2014516407A5 JP2014503629A JP2014503629A JP2014516407A5 JP 2014516407 A5 JP2014516407 A5 JP 2014516407A5 JP 2014503629 A JP2014503629 A JP 2014503629A JP 2014503629 A JP2014503629 A JP 2014503629A JP 2014516407 A5 JP2014516407 A5 JP 2014516407A5
Authority
JP
Japan
Prior art keywords
seq
derived
human
protein
condition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014503629A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014516407A (ja
JP6227523B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2012/050352 external-priority patent/WO2012138284A1/en
Publication of JP2014516407A publication Critical patent/JP2014516407A/ja
Publication of JP2014516407A5 publication Critical patent/JP2014516407A5/ja
Application granted granted Critical
Publication of JP6227523B2 publication Critical patent/JP6227523B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014503629A 2011-04-05 2012-03-30 治療の方法においておよび化合物のスクリーニングのために有用なアミロドーシスターゲット Expired - Fee Related JP6227523B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1150299-4 2011-04-05
SE1150299 2011-04-05
PCT/SE2012/050352 WO2012138284A1 (en) 2011-04-05 2012-03-30 Amyloidosis target useful in methods of treatment and for screening of compounds

Publications (3)

Publication Number Publication Date
JP2014516407A JP2014516407A (ja) 2014-07-10
JP2014516407A5 true JP2014516407A5 (https=) 2015-05-14
JP6227523B2 JP6227523B2 (ja) 2017-11-08

Family

ID=46085122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014503629A Expired - Fee Related JP6227523B2 (ja) 2011-04-05 2012-03-30 治療の方法においておよび化合物のスクリーニングのために有用なアミロドーシスターゲット

Country Status (4)

Country Link
US (1) US9522170B2 (https=)
EP (1) EP2694977B1 (https=)
JP (1) JP6227523B2 (https=)
WO (1) WO2012138284A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2391379B1 (en) 2009-01-30 2017-08-02 Alphabeta AB Compound and method for treatment of alzheimer's disease
US11077095B2 (en) * 2017-02-24 2021-08-03 Alzheon, Inc. Methods for treating neurodegenerative disorders
US20230002458A1 (en) * 2020-01-08 2023-01-05 Alphabeta Ab Compound and method for treatment of alzheimer's disease

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003170A1 (en) 1986-10-24 1988-05-05 Whitsett Jeffrey A Pulmonary hydrophobic surfactant-associated proteins
MXPA01004317A (es) 1998-10-30 2003-06-06 Jordan L Holtzman Un complejo de una chaperona con -amiloideo y metodos que emplean este complejo.
US6670195B1 (en) * 1999-05-26 2003-12-30 New York University Mutant genes in Familial British Dementia and Familial Danish Dementia
US20030224982A1 (en) 2001-07-05 2003-12-04 Li Li Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US6673545B2 (en) 2000-07-28 2004-01-06 Incyte Corporation Prostate cancer markers
US6716589B2 (en) 2000-11-20 2004-04-06 Alphabeta Ab Discordant helix stabilization for prevention of amyloid formation
WO2002094259A1 (en) * 2001-05-03 2002-11-28 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Compounds that inhibit hsp90 and stimulate hsp70 and hsp40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formation
AU2003223718B2 (en) 2002-04-25 2007-08-16 The Scripps Research Institute Treatment and prevention of pulmonary conditions
WO2004056310A2 (en) 2002-12-09 2004-07-08 Children's Hospital Medical Center Methods of diagnosis and treatment of interstitial lung disease
AU2003298171A1 (en) * 2003-09-05 2005-03-29 Cellzome Ag Protein complexes associated with app-processing
DE602004008658T2 (de) * 2003-09-05 2008-06-12 Cellzome Ag Behandlung neurodegenerativer krankheiten
US7794948B2 (en) * 2003-11-07 2010-09-14 Vermilllion, Inc. Biomarkers for alzheimer's disease
EP1694314A4 (en) 2003-12-04 2009-07-01 Scripps Research Inst TREATMENT AND PREVENTION OF ASTHMA
RU2396090C2 (ru) 2004-04-05 2010-08-10 Дзе Юниверсити Оф Токушима Носитель лекарства-антигена, дающий возможность трансмукозального и трансдермального введения, способ индуцирования мукозального иммунитета, мукозальная вакцина и система доставки лекарства, использующие его
WO2006138355A2 (en) 2005-06-14 2006-12-28 Albert Einstein College Of Medicine Of Yeshiva University Effect of bri proteins on abeta production
WO2007005672A2 (en) 2005-06-30 2007-01-11 The Scripps Research Institute Treatment and prevention of respiratory diseases and conditions
EP1930025B1 (en) 2005-08-05 2013-05-01 The University of Tokushima ANTIGEN-AND-DRUG VEHICLE WHICH ENABLES THE CHANGEOVER FROM THE SELECTIVE PRODUCTION OF IgA ANTIBODY TO THE PRODUCTION OF BOTH OF IgA AND IgG ANTIBODIES, AND TRANSNASAL/TRANSMUCOSAL VACCINE USING THE VEHICLE
JP4981305B2 (ja) * 2005-11-11 2012-07-18 公益財団法人大阪バイオサイエンス研究所 アルツハイマー病の発症リスク又はアルツハイマー病発症予後の予測方法
CA2706535A1 (en) 2006-11-22 2008-06-05 Albert Einstein College Of Medicine Of Yeshiva University Transgenic mammals modified in bri protein expression
AU2008259768B2 (en) 2007-06-05 2013-08-29 Paka Pulmonary Pharmaceuticals, Inc. Compositions for delivering medicaments into the lungs, uses thereof
WO2009009396A2 (en) 2007-07-06 2009-01-15 Mayo Foundation For Medical Education And Research Bri polypeptides and reducing ab aggregation
EP2391379B1 (en) 2009-01-30 2017-08-02 Alphabeta AB Compound and method for treatment of alzheimer's disease
JP5339387B2 (ja) 2009-08-10 2013-11-13 独立行政法人科学技術振興機構 オートファジーの測定方法
AU2010356144B2 (en) 2010-06-24 2015-06-04 Alphabeta Ab Compound and method for treatment of Alzheimer's disease and familial dementia

Similar Documents

Publication Publication Date Title
Von Kobbe Targeting senescent cells: approaches, opportunities, challenges
Woodruff et al. The role of the complement system and the activation fragment C5a in the central nervous system
Lu et al. Targeting WWP1 ameliorates cardiac ischemic injury by suppressing KLF15-ubiquitination mediated myocardial inflammation
Lv et al. Klotho alleviates indoxyl sulfate-induced heart failure and kidney damage by promoting M2 macrophage polarization
EP2149584B1 (en) Method for enhancing immune response with peptide
JP2017158561A5 (https=)
WO2013043720A1 (en) Regulation of sodium channels by plunc proteins
CA3020580A1 (en) Peptide compounds to regulate the complement system
Wang et al. Let-7a gene knockdown protects against cerebral ischemia/reperfusion injury
Matharu et al. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease
EP3724232A1 (en) Exosome packaging and targeted autophagy
US9156889B2 (en) Drug transporter permeating blood-brain barrier, peptide and use thereof
Zhang et al. Neutrophil extracellular traps aggravate neuronal apoptosis and neuroinflammation via neddylation after traumatic brain injury
US20190111111A1 (en) Treatment of Cerebral Cavernous Malformations
JP2014516407A5 (https=)
Granic et al. LPYFDa neutralizes amyloid-β-induced memory impairment and toxicity
CN105745219B (zh) 结合β淀粉状蛋白的肽及其用于治疗和诊断阿尔茨海默痴呆症的用途
JP7820821B2 (ja) アルツハイマー病の治療のための化合物及び方法
CN107428811B (zh) 用于治疗和/或诊断阿尔茨海默氏痴呆症的特异性结合A-β-物类的肽
US20200031873A1 (en) Repurposing cell penetrating peptides and their novel derivatives and iopromide and iodo-aryl carbonates for treatment of senescence-related diseases and disorders
Liu et al. Biological effects and mechanism of β-amyloid aggregation inhibition by penetrable recombinant human HspB5-ACD structural domain protein
US10400009B2 (en) β-sheet breaker peptide used for preventing and/or treating alzheimer's disease
JP2016516756A (ja) 転移のインヒビター
Xie et al. From stem cells to nanomedicine: A multimodal approach targeting pancreatic fibrosis via MFGE8-dependent ANXA1-SMAD2/3 axis
WO2014060580A9 (en) Lxvp-mediated calcineurin inhibition in macrophages